The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease.
The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were rs=0.632, P<0.001 and rs=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease.
McArdle
P A
PA
University Department of Surgery, Royal Infirmary, Glasgow, UK.
McMillan
D C
DC
Sattar
N
N
Wallace
A M
AM
Underwood
M A
MA
D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011469:Prostatic Diseases / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000097:blood*
D015850:Interleukin-6; D002097:C-Reactive Protein